Visual Prognosis of Disciform Degeneration in Myopia
References (10)
- et al.
Axial length measurements and fundus changes of the myopic eye
Am J Ophthalmol
(1971) - et al.
Pathologic myopia and choroidal neovascularization
Am J Ophthalmol
(1981) - et al.
Follow-up study in eyes with choroidal neovascularizatlon caused by presumed ocular nlstoplasmosis
Am J Ophthalrnol
(1977) Der centrale schwarze Fleck bei Myopie
Z Augenheilkd
(1901)
Cited by (138)
The other CNVM: A review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agents
2015, Survey of OphthalmologyCitation Excerpt :Studies suggest that CNVM is most frequently subfoveal in myopia, and the rate of recurrence of CNVM is as high as 72% after laser photocoagulation. The scar expansion occurs most frequently at the foveal edge of the laser scar.28,64,69 In fact, one study of 19 eyes with PM demonstrated progressive enlargement of the photocoagulation scar in 89%, with a resulting decrease in VA in 68%.36
Treatment of myopic choroidal neovascularization: Recommendations of theFederation France
2014, Journal Francais d'OphtalmologieEpidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: An evidence-based systematic review
2014, American Journal of OphthalmologyCitation Excerpt :In the Beijing Eye Study, mean BCVA was logMAR 0.88 (41 letters) for individuals with pathologic myopia compared with logMAR 0.56 (57 letters) for individuals without pathologic myopia (P < .001).24 Eleven studies reported on visual outcome for patients with myopic CNV followed up for durations ranging from under 3 months to 21.5 years (Table 6).38–48 At baseline, the proportion of patients with a BCVA of 20/200 or worse ranged from 21%-60% in 8 studies reporting this measure.
Presented at the 1982 Eighty-seventh Annual Meeting of the American Academy of Ophthalmology, San Francisco, California, October 30–November 5, 1982.